WSJ's blog on health and the business of health.

Visit WSJ.com: Health Blog

Traders Boost Bayer on Pfizer Deal Speculation

Posted on September 09, 2008

Bayer shares are up more than 4% in Europe on rumors that Pfizer is eyeing the German company for purchase. There s speculation in the market today that Pfizer may bid for Bayer, Manfred Groeschel, an equity trader at Merck Finck & Co. in Munich, told Bloomberg. Bayer s HealthCare division makes drugs including the impotence pill Levitra, a rival to Viagra, as well as contrast agents used to enhance X-rays and MRI scans.Dow Jones Newswires reported that the story on the trading floors is that Pfizer is talking with key investors in the German company in advance of a bid. But not ever...

Original article link


viagra